Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Syneos Health | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Syneos Health

Results include combined INC Research and inVentiv merger

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Syneos Health
4Q Revenues: $1.1 billion (revenues were $406.1 million 4Q16)
4Q Loss: $15.0 million (earnings were $37.5 million 4Q16)
FY Revenues: $2.7 billion (revenues were $1.6 billion FY16)
FY Loss: $138.5 million (earnings were $112.6 million FY16)
Comments: Combined Company new business awards were $622.9 million in the quarter and $2.55 billion for the full year 2017 representing growth of 16.5% for the full year 2017. Combined Company book-to-bill ratio of 1.16x for the quarter and 1.20x for the full year 2017. The combined company includes financial information of INC Research and inVentiv Health.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters